Profusa (PFSA) Cash from Financing Activities (2023 - 2026)
Profusa's (PFSA) quarterly Cash from Financing Activities came in at $28000.0 in Q1 2026, down 92.33% year-on-year from $365000.0 in Q1 2025, and down 99.43% quarter-over-quarter from $4.9 million in Q4 2025.
Profusa (PFSA) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Profusa's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $28000.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 92.33% year-over-year to $28000.0 in Q1 2026; TTM through Mar 2026 was $19.5 million, a 310.2% increase from a year earlier, with the FY2025 full-year figure at $19.8 million, up 838.2% from the prior year.
- Cash from Financing Activities slipped to $28000.0 in Q1 2026 per PFSA's latest filing, from $4.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $20.9 million in Q3 2025 and bottomed at -$184.8 million in Q1 2023.
- The 4-year median for Cash from Financing Activities is $343426.0 (2023), against an average of -$12.4 million.
- Biggest YoY gain for Cash from Financing Activities was 1597.58% in 2025; the steepest drop was 2025.11% in 2025.
- Year by year, Cash from Financing Activities stood at $408800.0 in 2023, then declined by 29.31% to $289000.0 in 2024, then jumped by 1597.58% to $4.9 million in 2025, then sank by 99.43% to $28000.0 in 2026.
- Per Business Quant, the three latest PFSA Cash from Financing Activities figures stand at $28000.0 (Q1 2026), $4.9 million (Q4 2025), and $20.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | 28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,000.00 |
| Mar 31, 2026 | 28,000.00 |
| Dec 31, 2025 | 4.91 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 20.94 Mn |
| Sep 30, 2025 | 20.94 Mn |
| Jun 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | -6.37 Mn |
| Mar 31, 2025 | 365,000.00 |
| Mar 31, 2025 | 365,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Sep 30, 2024 | 3.77 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 330,796.00 |
| Jun 30, 2024 | 330,796.00 |
| Mar 31, 2024 | -2.28 Mn |
| Mar 31, 2024 | -2.28 Mn |
| Dec 31, 2023 | 408,800.00 |
| Dec 31, 2023 | 408,800.00 |